SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Clorox Co/DE – ‘8-K’ for 11/20/19

On:  Friday, 11/22/19, at 4:15pm ET   ·   For:  11/20/19   ·   Accession #:  1206774-19-3738   ·   File #:  1-07151

Previous ‘8-K’:  ‘8-K’ on 11/18/19 for 11/15/19   ·   Next:  ‘8-K’ on / for 2/4/20   ·   Latest:  ‘8-K’ on / for 3/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/22/19  Clorox Co/DE                      8-K:5      11/20/19   10:217K                                   DG3/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     39K 
 5: R1          Cover                                               HTML     49K 
10: XML         IDEA XML File -- Filing Summary                      XML     11K 
 8: XML         XBRL Instance -- clorox3678131-8k_htm                XML     15K 
 6: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- clx-20191120_lab                      XML     98K 
 3: EX-101.PRE  XBRL Presentations -- clx-20191120_pre               XML     65K 
 2: EX-101.SCH  XBRL Schema -- clx-20191120                          XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
 7: ZIP         XBRL Zipped Folder -- 0001206774-19-003738-xbrl      Zip     12K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0000021076  i false  i CLOROX CO /DE/ 0000021076 2019-11-19 2019-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________

FORM  i 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i November 20, 2019

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
__________________

 i Delaware  i 1-07151  i 31-0595760
(State or other jurisdiction of       (Commission File Number)       (I.R.S. Employer
incorporation) Identification No.)

 i 1221 Broadway,  i Oakland,  i California  i 94612-1888
(Address of principal executive offices) (Zip code)

( i 510)  i 271-7000
(Registrant's telephone number, including area code)

 i Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 i [ ]   Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
 
 i [ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 i [ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 i [ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Name of each exchange on which registered
Symbol(s)
 i Common Stock - $1.00 par value  i CLX  i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company      i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐


Item 5.07 Submission of Matters to a Vote of Security Holders.

On November 20, 2019, The Clorox Company (the “Company”) held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:

        1.         The Company’s stockholders elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.
 
Number of Votes
      For       Against       Abstain       Broker Non-Votes
Amy Banse 88,139,990 569,951 218,124 21,069,742
Richard H. Carmona 85,595,295 3,093,550 239,220 21,069,742
Benno Dorer 85,233,045 3,159,541 535,479 21,069,742
Spencer C. Fleischer 87,319,078 1,330,336 278,651 21,069,742
Esther Lee 88,115,306 568,872 243,887 21,069,742
A.D. David Mackay 88,331,328 330,023 266,714 21,069,742
Robert W. Matschullat 85,735,605 2,928,324 264,136 21,069,742
Matthew J. Shattock 88,071,571 600,545 255,949 21,069,742
Pamela Thomas-Graham 85,531,713 3,169,072 227,280 21,069,742
Russell Weiner 87,791,923 879,359 256,783 21,069,742
Christopher J. Williams 88,042,111 628,369 257,585 21,069,742
 
        2.         The Company’s stockholders voted for (on an advisory basis) the approval of the compensation of the Company’s named executive officers.
 
        Number of Votes
For       Against       Abstain       Broker Non-Votes
81,851,649 6,406,875 669,259 21,070,024
 
        3.         The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2020.
 
        Number of Votes
For       Against       Abstain       Broker Non-Votes
107,970,846 1,629,225 397,736 0
 

 
        4.         The Company’s stockholders did not approve the proposed amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision. Under the Company’s Restated Certificate of Incorporation, the affirmative vote of at least 80% of the outstanding voting stock is required to approve this proposal. The 87,544,878 votes in favor of this proposal represented 69.76% of the total outstanding shares of common stock.
 
        Number of Votes
For       Against       Abstain       Broker Non-Votes
87,544,878 866,508 516,679 21,069,742
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY
 
Date: November 22, 2019       By:   /s/ Laura Stein
Executive Vice President –
      General Counsel and Corporate Affairs
 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
6/30/2010-K,  4
Filed on:11/22/194
For Period end:11/20/19DEF 14A,  PRE 14A
 List all Filings 
Top
Filing Submission 0001206774-19-003738   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 10:59:25.1am ET